
In the phase 2 ZUPREME 1 trial, the once-weekly amylin analog was well tolerated, with nausea mostly mild and limited to dose escalation.
Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, describes the general treatment approach for allergic rhinitis.
Mary M. Bridgeman, PharmD, BCPS, CGP, clinical associate professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy at Rutgers, describes the general treatment approach for allergic rhinitis.
This video was recorded at Directions in Pharmacy's 5th annual CE conference in March 2015.






